LONG FACTOR CERTIFICATE - PFIZER INC | Market Closed - Euronext Paris 12:30:01 2024-05-31 pm EDT | ||
| 0.61 EUR | +24.49% |
|
| Current month | +110.34% | ||
| 1 month | +110.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
| Date | Price | Change |
|---|---|---|
| 24-05-31 | 0.61 | +24.49% |
| 24-05-30 | 0.49 | +6.52% |
| 24-05-29 | 0.46 | -22.03% |
| 24-05-28 | 0.59 | -32.18% |
| 24-05-27 | 0.87 | +17.57% |
Real-time Euronext Paris
Last update May 31, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | Goldman Sachs |
| Y2HQH | |
| ISIN | DE000GQ8Z3D8 |
| Date issued | 2023-11-14 |
| Strike | 26.04 $ |
| Maturity | Unlimited |
| Parity | 3.74 : 1 |
| Emission price | 21.85 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 37.63 € |
|---|---|
| Lowest since issue | 0.24 € |
| Spread | 0.01 € |
| Spread % | 1.61% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66
USD
Average target price
31.92
USD
Spread / Average Target
+11.36%
- Stock Market
- Certificates
- Y2HQH Certificat
